Clinical Trials Logo

Filter by:
NCT ID: NCT05586854 Not yet recruiting - Clinical trials for Chronic Renal Failure

Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia

MODIATIH
Start date: November 20, 2022
Phase: N/A
Study type: Interventional

This research is based on the hypothesis that the Hydrolink®-NV dialysis membrane could allow the realization of quality dialysis with a significant reduction in the doses of Orgaran®, or even a total cessation of the anticoagulant, in patients with chronic renal failure. with heparin-induced thrombocytopenia. Thus, this study aims to show that the use of this dialysis membrane without prior anticoagulation does not increase the risk of coagulation of the circuit and allows the realization of quality dialysis sessions.

NCT ID: NCT05586672 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

HR-EEG Contribution in Prognostic Evaluation of Language Development in Children With ASD

EE-TSA-LANG
Start date: January 2, 2023
Phase:
Study type: Observational

The goal of this prospective observational multicentric cohort study is to evaluate the clinical prognostic value of the speech tracking score of language development in children with ASD aged from 3 years to 4 years and half at inclusion. Participants will followed during 4 years with an annual visit. During these visits, each participant will be clinically evaluated (scales and tests) and performed an EEG-HR recording. Two groups will be formed, one with children diagnosed with ASD with language delay, and a control group composed of non-ASD children without language delay, matched on age and gender with the ASD group.

NCT ID: NCT05586607 Completed - Aseptic Meningitis Clinical Trials

Causes and Management of Aseptic Meningitis : A Retrospective Cohort Study in Strasbourg University Hospital

Meningitis
Start date: May 20, 2021
Phase:
Study type: Observational

The diagnostic and therapeutic management of patients with aseptic meningitis is a challenge for the practitioner. There are many etiologies of this condition (infectious, inflammatory, neoplastic, drug-induced), which it is necessary to know how to evoke and look for specifically.

NCT ID: NCT05586555 Terminated - Clinical trials for Hearing Loss, Sensorineural

A Monocentric Study Evaluating Pupillometry as an Objective Measurement for CI Fittings

PupillOM
Start date: May 2, 2023
Phase: N/A
Study type: Interventional

This trial is a monocentric, prospective and controlled study of the pupil response to detect hearing threshold and comfortable loudness of normal-hearing (NH) and CI-subjects.

NCT ID: NCT05586334 Recruiting - Preterm Labor Clinical Trials

Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)

PrediMAP
Start date: June 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to clinically validate the predictive performance (sensitivity and specificity) of the PrediMAP in-vitro diagnostic medical device to predict delivery within 7 days in the target population of women consulting obstetric emergencies for preterm labor (PTL).

NCT ID: NCT05585528 Recruiting - Ligament Rupture Clinical Trials

Informing the Patient on the Type of Management, Surgical or Functional, After Rupture of the Anterior Cruciate Ligament

INFO-LCA
Start date: December 20, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the proportion of patients after rupture of the anterior cruciate ligament (ACL) of the knee, who will have functional or surgical management (PEC) in 1st intention, after having received appropriate information.

NCT ID: NCT05585489 Completed - Parkinson Disease Clinical Trials

Individualization of Music-based Cueing During Gait in Parkinson's Disease.

MUSIGAIT
Start date: June 22, 2021
Phase: N/A
Study type: Interventional

Spatio-temporal correction of the step is a key component of gait rehabilitation in Parkinson's disease. Walking rehabilitation techniques using visual or auditory cueing of the cadence or step length have been tested to prevent or correct the lack of consistency of the step. An auditory cue of the duration of the step, encouraging it to be extended according to patient own capacities during gait has been proposed. The cue is integrated into music and is presented in an open-loop approach. The present study aimed to evaluate the effect of the individual music-based cueing of the step length on gait in Parkinson's disease.

NCT ID: NCT05584930 Recruiting - Febrile Neutropenia Clinical Trials

Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN)

CluPPFeN
Start date: October 10, 2022
Phase: N/A
Study type: Interventional

Febrile aplasia is a common occurrence in children/adults treated with chemotherapy for malignant blood diseases or solid cancers. This acquired deficiency of immunity mainly causes susceptibility to bacterial and fungal infections, pathogens normally recognized by specific receptors of innate immunity (Pattern Recognition Receptor, PRR). Thus, the febrile episodes in the context of post-chemotherapy neutropenia can be bacterial or fungal etiology, but can also frequently be related to viral infections, toxic phenomena or other etiologies. In the absence of a discriminating marker, treatment for all these children is based on early, broad-spectrum antibiotic therapy in hospital. Septic shock or even death by refractory septic shock remain, even if they are rare, real complications in pediatric oncology, requiring discriminatory markers for effective management, While trying to reduce the number and duration of hospitalizations for children at low risk for severe febrile aplasia. It is therefore necessary to identify other markers allowing the earliest possible classification of episodes of febrile aplasia. A previous study, conducted by our team, PTX3 and febrile aplasia, studied pentraxin 3 (PTX3), a soluble PRR of the pentraxin family that plays a key role in immune surveillance against pathogens. Preliminary results obtained from samples from a cohort of patients treated in adult hematology and pediatric onco-hematology support a prognostic character of PTX3 in the severity of aplasia, with higher elevations of serum protein during episodes of severe sepsis or septic shock (ongoing analyses and interpretations for the adult population). The available data to date on the pediatric cohort are insufficient to conclude on the value of using PTX3. The investigators therefore wish to create a new paediatric cohort, in order to evaluate the PTX3 levels for the paediatric population and also to perform the assay of a new marker, clusterin. Clusterin (CLU) is an extracellular chaperone protein of constitutive expression. The Innate Immunity team of the National Institute of Health and Medical Research (INSERM) "1307-Scientific Research National Center (CNRS) 6075" unit has shown that Clu binds to extracellular histones and inhibits their inflammatory, thrombotic and cytotoxic properties. The investigators also observed (i) that in adults without severe sepsis neutropenics, low serum levels of Clu at intake and lack of normalization of rates are associated with higher mortality and (ii) Clu levels are inversely correlated with circulating histone levels. All these data suggest that Clu would have a protective role for histone-induced lesions during sepsis independently of antibiotic treatment, opening an innovative therapeutic pathway in the management of severe sepsis. CluPPFeN is based on the hypothesis that, in a pediatric population with episodes of febrile aplasia, serum Clu and serum PTX3 levels would discriminate between febrile episodes caused by bacterial infection and other etiologies and, As a result, would reduce the consumption of antibiotics, which provide resistance, and the length of hospitalization.

NCT ID: NCT05584917 Recruiting - Clinical trials for Popliteal Artery Entrapment

Physical Activity Return After Popliteal Artery Entrapement Syndrome Surgery

PAES
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

evaluation of physical activity return after popliteal artery entrapement syndrome surgery with the tegner activity scale

NCT ID: NCT05584527 Recruiting - Eating Habit Clinical Trials

Assessment of the Effects of a 24-hour Cold and Heat Exposure on the Factors Influencing Food Intake

TEMPCA
Start date: November 28, 2022
Phase:
Study type: Observational

Military personnel and athletes have a very high energy expenditure which is increased during certain key periods (intense training, competition and mission). Compensating for this expenditure through food can be complicated by physiological ingestive limits and logistical and organizational constraints (number of meals, availability of food), which leads these populations to regularly experience energy deficit situations (intake below requirements), which could alter physical and cognitive performance and major physiological functions. Among the many constraints to which military personnel and athletes are exposed to (stress, sleep deprivation, travel, etc.) that can increase the risk of energy deficits, the impact of thermal environmental constraints is not well known. The seasonal impact and travel to countries with very different thermal environments can lead these populations to experience cold and hot conditions for long periods. Understanding how heat and cold exposure modifies appetite and energy intake therefore appears to be of great importance. The hypothesis of this study is that a 24 h heat exposure would produce a rapid and long-lasting anorexigenic action impacting energy intake, while a cold exposure would produce the opposite effect (orexigenic action).